BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1967352)

  • 1. Significance of residual leukaemia transcripts after bone marrow transplant for CML.
    Hughes T; Martiat P; Morgan G; Sawyers C; Witte ON; Goldman ON
    Lancet; 1990 Jan; 335(8680):50. PubMed ID: 1967352
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of BCR/ABL transcripts after BMT for CML detected by PCR reflects a high risk of relapse.
    Hughes TP; O'Shea P; Morgan G; Martiat P; Goldman JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():23. PubMed ID: 1878700
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
    Okamoto R; Harano H; Matsuzaki M; Motomura S; Maruta A; Kodama F; Mohri H; Okubo T
    Am J Clin Pathol; 1995 Nov; 104(5):510-6. PubMed ID: 7572810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patients.
    Guerrasio A; Zaccaria A; Rosso C; Scaravaglio P; Rege Cambrin G; Bertolli VG; Saglio G; Tassinari A; Testoni N; Rosti G
    Bone Marrow Transplant; 1991; 7 Suppl 2():22. PubMed ID: 1878699
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
    Langabeer SE; Gale RE; Harvey RC; Cook RW; Mackinnon S; Linch DC
    Leukemia; 2002 Mar; 16(3):393-9. PubMed ID: 11896544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinical relapse after bone-marrow transplantation by PCR for Philadelphia-positive acute lymphoblastic leukaemia.
    Miyamura K; Morishima Y; Tanimoto M; Saito H; Kojima S; Kodera Y; Mizutani S
    Lancet; 1990 Oct; 336(8719):890. PubMed ID: 1976927
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
    Sawyers CL; Timson L; Kawasaki ES; Clark SS; Witte ON; Champlin R
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):563-7. PubMed ID: 2405384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction.
    Cross NC; Feng L; Bungey J; Goldman JM
    Leuk Lymphoma; 1993; 11 Suppl 1():39-43. PubMed ID: 8251914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
    Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
    Guerrasio A; Martinelli G; Saglio G; Rosso C; Zaccaria A; Rosti G; Testoni N; Ambrosetti A; Izzi T; Sessarego M
    Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of chimeric transcript detection in CML patients after bone marrow transplantation.
    Martinelli G; Sessarego M; Gasparini P; Ambrosetti A; Frassoni F; Chiamenti AM; Pignatti PF
    Bone Marrow Transplant; 1991; 7 Suppl 2():21. PubMed ID: 1878698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of T-depleted BMT in chronic myelogenous leukaemia after a conditioning regimen that included thiotepa.
    Aversa F; Pelicci PG; Terenzi A; Carotti A; Felicini R; Mencarelli A; Donti E; Latini P; Aristei C; Martelli MF
    Bone Marrow Transplant; 1991; 7 Suppl 2():24. PubMed ID: 1908727
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymerase chain reaction for detection of residual leukaemia.
    Morgan GJ; Hughes T; Janssen JW; Gow J; Guo AP; Goldman JM; Wiedemann LM; Bartram CR
    Lancet; 1989 Apr; 1(8644):928-9. PubMed ID: 2565420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.
    Dickinson AM; Middleton SL; Latham J; Dunn J; Thomas L; Proctor SJ
    Leukemia; 1995 Mar; 9(3):444-9. PubMed ID: 7533866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.
    Maurer J; Janssen JW; Thiel E; van Denderen J; Ludwig WD; Aydemir U; Heinze B; Fonatsch C; Harbott J; Reiter A
    Lancet; 1991 May; 337(8749):1055-8. PubMed ID: 1673492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatment.
    Wandl UB; Bützler R; Niederle N; Kloke O; Mengelkoch B; Becher R; Seeber S; Opalka B
    Leukemia; 1994 May; 8(5):776-9. PubMed ID: 7514245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia.
    Pignon JM; Henni T; Amselem S; Vidaud M; Duquesnoy P; Vernant JP; Kuentz M; Cordonnier C; Rochant H; Goossens M
    Leukemia; 1990 Feb; 4(2):83-6. PubMed ID: 2406520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation.
    Gabert J; Thuret I; Lafage M; Carcassonne Y; Maraninchi D; Mannoni P
    Lancet; 1989 Nov; 2(8672):1125-8. PubMed ID: 2572849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.